12.83
Trevi Therapeutics Inc Azioni (TRVI) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Operating Expenses |
37.53%
20.51
|
14.91 | 10.22 | 13.92 | 13.72 |
| Operating Income/Loss |
37.53%
-20.51
|
-14.91 | -10.22 | -13.92 | -13.72 |
| Nonoperating Income/Loss |
58.41%
2.693
|
1.70 | 1.888 | 2.099 | 1.40 |
| Income/Loss From Continuing Operations Before Tax |
34.85%
-17.82
|
-13.21 | -8.332 | -11.82 | -12.32 |
| Income Tax Expense/Benefit |
5.00%
-0.019
|
-0.02 | -0.016 | -0.015 | -0.021 |
| Net Income/Loss |
34.91%
-17.80
|
-13.19 | -8.316 | -11.80 | -12.30 |
| Basic Average Shares |
7.56%
156.60
|
145.59 | - | 145.10 | 130.35 |
| Diluted Average Shares |
7.56%
156.60
|
145.59 | - | 145.10 | 130.35 |
| Basic Earnings Per Share |
22.22%
-0.11
|
-0.09 | - | -0.08 | -0.09 |
| Diluted Earnings Per Share |
22.22%
-0.11
|
-0.09 | - | -0.08 | -0.09 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):